Open vs robot-assisted laparoscopic gastric resection with D2 lymph node dissection for adenocarcinoma: a case-control study

2011 ◽  
Vol 7 (4) ◽  
pp. 452-458 ◽  
Author(s):  
Stefano Caruso ◽  
Alberto Patriti ◽  
Daniele Marrelli ◽  
Graziano Ceccarelli ◽  
Cecilia Ceribelli ◽  
...  
Keyword(s):  
Lymph Node ◽  
Lymph Node Dissection ◽  
Gastric Resection ◽  
Case Control Study ◽  
Case Control ◽  
Node Dissection ◽  
Robot Assisted ◽  
D2 Lymph Node Dissection ◽  
Laparoscopic Gastric Resection ◽  
Control Study

scholarly journals The optimal extent of lymph node dissection in gastroesophageal junctional cancer: retrospective case control study

BMC Cancer ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Won Ho Han ◽  
Bang Wool Eom ◽  
Hong Man Yoon ◽  
Daniel Reim ◽  
Young-Woo Kim ◽  
...  
Keyword(s):  
Lymph Node ◽  
Lymph Node Dissection ◽  
Case Control Study ◽  
Case Control ◽  
Node Dissection ◽  
Retrospective Case ◽  
Control Study

Robot-assisted laparoscopic total and partial gastric resection with D2 lymph node dissection for adenocarcinoma

2008 ◽  
Vol 22 (12) ◽  
pp. 2753-2760 ◽  
Author(s):  
Alberto Patriti ◽  
Graziano Ceccarelli ◽  
Raffaele Bellochi ◽  
Alberto Bartoli ◽  
Alessandro Spaziani ◽  
...  
Keyword(s):  
Lymph Node ◽  
Lymph Node Dissection ◽  
Gastric Resection ◽  
Node Dissection ◽  
Robot Assisted ◽  
D2 Lymph Node Dissection

scholarly journals Preliminary Results of Robotic Lobectomy in Stage IIIA-N2 NSCLC after Induction Treatment: A Case Control Study

2021 ◽  
Vol 10 (16) ◽  
pp. 3465
Author(s):  
Monica Casiraghi ◽  
Francesco Petrella ◽  
Giulia Sedda ◽  
Antonio Mazzella ◽  
Juliana Guarize ◽  
...  
Keyword(s):  
Lymph Node ◽  
Minimally Invasive ◽  
Open Surgery ◽  
Case Control Study ◽  
Locally Advanced ◽  
Case Control ◽  
Induction Treatment ◽  
Stage Iiia ◽  
Robot Assisted ◽  
Control Study

Despite there already being many studies on robotic surgery as a minimally invasive approach for non-small-cell lung cancer (NSCLC) patients, the use of this technique for stage III disease is still poorly described. These are the preliminary results of our prospective study on the safety and effectiveness of robotic approaches in patients with locally advanced NSCLC in terms of postoperative complications and oncological outcomes. Since 2016, we prospectively investigated 19 consecutive patients with NSCLC stage IIIA-pN2 (diagnosed by EBUS-TBNA) who underwent lobectomy and radical lymph node dissection with robotic approaches after induction treatment. Furthermore, we matched a case-control study with 46 patients treated with open surgery during the same period of time, with similar age, comorbidities, clinical stage and tumor size. The individual matched population was composed of 16 robot-assisted thoracic surgeries and 16 patients who underwent open surgery. The median time range of resection was inferior in the open group compared to robotic lobectomy (243 vs. 161 min; p < 0.001). Lymph node resection and positivity were not significantly different (p = 0.96 and p = 0.57, respectively). Moreover, no difference was observed for PFS (p = 0.16) or OS (p = 0.41). In conclusion, we demonstrated that the early outcomes and oncological results of N2-patients after robotic lobectomy were similar to those who had open surgery. Considering the advantages of minimally invasive surgery, robot-assisted lobectomy appears to be a safe approach to patients with locally advanced diseases.

Sign in / Sign up

Export Citation Format

Share Document